Department of Pharmacology, Research Center of Pharmacology and Experimental Therapeutics, Ernst Moritz Arndt University, 17487 Greifswald, Germany.
J Biol Chem. 2010 Apr 9;285(15):11336-47. doi: 10.1074/jbc.M109.056457. Epub 2010 Feb 16.
Members of the organic anion transporting polypeptide (OATP) family are involved in various pharmacological, pathophysiological, and physiological processes, such as hepatic drug uptake, progress of cancer, or transport of hormones. Although variability in expression and function of OATPs has been investigated in detail, data concerning regulation are rather limited. Here, we report a novel mechanism for rapid regulation of OATP2B1 mediated by protein kinase C (PKC) resulting in significant changes of transport activity. PKC activation by the phorbol ester (phorbol 12-myristate 13-acetate, PMA) resulted in increased phosphorylation of OATP2B1 as well as reduced OATP2B1 transport activity with a decrease in V(max) of E(1)S uptake (288 +/- 21 (control) versus 165 +/- 16 pmol/min/mg of protein (PMA)). This effect was sensitive to the PKC inhibitor bisindolylmaleimide I (BIM-I). Confocal microscopy, fluorescence-based internalization assay, and live-cell imaging using green fluorescent protein-tagged OATP2B1 revealed that transport inhibition was due to internalization of the transporter. Furthermore, colocalization with LAMP-2 and chloroquine-sensitive degradation of OATP2B1 suggest that the internalized protein is targeted to a lysosomal degradation pathway. With regard to the underlying mechanism inhibition of caveolin/lipid raft-mediated endocytosis failed to prevent OATP2B1 internalization, whereas inhibition of clathrin-mediated processes blocked OATP2B1 sequestration. However, small interfering RNA-mediated clathrin knock-down affected general trafficking of OATP2B1 and resulted in intracellular accumulation in the absence of PMA. In conclusion, our data demonstrate that OATP2B1 function is regulated by PKC-mediated, clathrin-dependent internalization and followed by lysosomal degradation. Furthermore, internalization could be shown in an ex vivo placenta perfusion. Our findings represent a new, rapid mechanism in regulation of human OATPs.
有机阴离子转运多肽(OATP)家族成员参与多种药理学、病理生理学和生理学过程,如肝药物摄取、癌症进展或激素转运。尽管已经详细研究了 OATP 的表达和功能变异性,但有关调节的数据相当有限。在这里,我们报告了一种新的机制,即蛋白激酶 C(PKC)快速调节 OATP2B1,导致转运活性发生显著变化。佛波酯(佛波醇 12-肉豆蔻酸 13-乙酸酯,PMA)激活 PKC 导致 OATP2B1 的磷酸化增加以及 OATP2B1 转运活性降低,E(1)S 摄取的 V(max)减少(288 +/- 21(对照)与 165 +/- 16 pmol/min/mg 蛋白(PMA))。这种效应对 PKC 抑制剂双吲哚马来酰亚胺 I(BIM-I)敏感。共聚焦显微镜、基于荧光的内化测定以及使用绿色荧光蛋白标记的 OATP2B1 的活细胞成像显示,转运抑制是由于转运体的内化。此外,与 LAMP-2 的共定位和氯喹敏感的 OATP2B1 降解表明,内化的蛋白质被靶向到溶酶体降解途径。关于潜在机制,抑制 caveolin/脂筏介导的内吞作用未能阻止 OATP2B1 的内化,而抑制网格蛋白介导的过程则阻止了 OATP2B1 的隔离。然而,小干扰 RNA 介导的网格蛋白敲低影响了 OATP2B1 的一般转运,并导致在没有 PMA 的情况下细胞内积累。总之,我们的数据表明 OATP2B1 的功能受 PKC 介导的网格蛋白依赖性内化和随后的溶酶体降解调节。此外,在体外胎盘灌注中可以显示内化。我们的发现代表了调节人 OATPs 的一种新的快速机制。